Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-007409

Options or other derivatives

  • Director acquired 92,537 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stansky Michael P Director 2026-02-04 Grant or award · Director Stock Option (right to buy) +92,537 92,537 D
Loading xslF345X05/wk-form4_1770853869.xml…